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Abstract
Background: Recent studies indicate that mural cells of the preglomerular vessels, known as cells of renin lineage
(CoRL), contribute to repair and regeneration of injured kidney glomeruli. However, their potential roles in
tubulointerstitial disease are less understood. The aim of this study was to better understand CoRL number
and distribution following UUO so that future mechanistic studies could be undertaken.
Methods: We mapped the fate of CoRL in adult Ren1cCreER x Rs-tdTomato-R reporter mice that underwent UUO.
Kidney biopsies from sham and UUO-subjected mice on days 3, 7, and 14 were evaluated by immunohistochemistry.
Results: In sham animals, CoRL were restricted to juxtaglomerular location. At day 7 following UUO, CoRL increased
two-fold, were perivascular in location, and co-expressed pericyte markers (PDGFßR, NG2), but did not express renin.
At day 14 post UUO, labeled CoRL detached from vessels and were present in the interstitium, in areas of fibrosis,
where they now expressed the myofibroblast marker alpha-smooth muscle actin. The increase in CoRL was
likely due to proliferation as marked by BrdU labeling, and migration from the cortex. Following UUO starting
from day 3, active hypoxia inducible factor-2α was detected in nuclei in labeled CoRL, in the cortex, but not
those cells found in medulla.
Conclusions: We have demonstrated that arteriolar CoRL are potential kidney progenitors that may contribute
to the initial vascular regeneration. However, in chronic kidney injury (≥14 days post UUO), perivascular CoRL
transition to myofibroblast-like cells.
Keywords: HIF-2α, UUO, Microvascular rarefaction, Pericytes, progenitor, Tubulointerstitial, PDGFßR, Fibrosis,
Hypoxia
Background
Unilateral ureteral obstruction (UUO), a commonly
used experimental model of chronic kidney injury is
characterized by tubular atrophy, inflammation and
interstitial fibrosis [1, 2]. In UUO, the initiating damage
is increased ureteral pressure transmitted retrograde to
the kidney that causes secondary renal vasoconstriction
and resultant reduced glomerular blood flow [3]. If the
pressure is not relived, the renal vascular resistance re-
mains increased, causing ischemia (reviewed in [4]).
The resultant tubulointerstitial fibrosis in UUO is
multi-factorial, including interstitial macrophages pro-
ducing pro-inflammatory cytokines, tubular cells undergo-
ing apoptosis, and resident renal cells transitioning to
collagen-producing cells [1]. The origin of the collagen
producing cells has been attributed to the perivascular cell
population, namely pericytes and perivascular fibroblasts.
Following UUO, perivascular cells become activated, and
detach from the underlying vessels. The consequences of
pericyte detachment include that endothelial cells are
deprived of survival factors [5], vascular tubes become
unstable and more permeable leading to microvascular
rarefaction [6], and migrating perivascular cells can de-
differentiate into myofibroblasts, thereby becoming a
source of collagen [7, 8].
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Less is understood the reparative, or attempted repara-
tive processes, if any, in UUO. Cells of renin lineage
(CoRL) refer to all possible cellular derivatives originating
from renin expressing cells at time captured by reporting.
Fate tracking studies showed that in development, CoRL
give rise to juxtaglomerular (JG) cells producing renin and
to non-renin-producing cells such as smooth muscle cells,
mesangial cells, tubular cells and extrarenal cells [9]. Re-
cently, the lineage relationship between Ren+ and Foxd1
+stromal cells was clarified when it was revealed that all
mural cells, including renin cells, are derived from Foxd1
stromal cells [10]. Studying CoRL (Ren+ progenitors) pro-
vides an opportunity to characterize in depth a subpopula-
tion of stromal cells. It is important because we need
better understanding of different subpopulation of stromal
cells to design specific therapeutic interventions [11].
Pericytes have gained recognition in the kidney for their
role in pathogenesis of fibrosis [7, 8]. Interestingly, CoRL
have been acclaimed as a candidate progenitor of the
kidney. Several studies showed that CoRL can regenerate
mesangial cells [12, 13], podocytes [14], parietal epithelial
cells [14], and erythropoietin-producing cells [15]. The
most recent study from our lab demonstrates that in
glomerular injury and remnant kidney models, CoRL mi-
grate to the interstitium and regenerate into pericytes [16].
The current study was designed to further explore the role
of CoRL in progressive tubulointerstitial injury, the experi-
mental model of unilateral ureteral obstruction.
Methods
Animals
To study the fate of renin lineage cells in chronic kidney
disease, we used RenCreER (Ren1cCreERxRs-tdTomato)
transgenic mice on a mixed C57 BL10/C3H background
[16]. In RenCreER mice, cells of renin lineage are only
labeled permanently in inducible manner with tdTomato
red protein within temporal windows defined by the
administration of tamoxifen. 8–9 week-old mice were
given Tamoxifen (100 mg/kg) by IP injection for 6 days on
alternate days, as we have previously reported [16, 17]. We
waited at least 7 weeks between giving tamoxifen and
inducing the disease model, to allow significant washout
of tamoxifen to exclude possibility of recombination in
other cell types. Animal protocols were approved by the
University of Washington Institutional Animal Care and
Use Committee (2968-04).
Experimental model of kidney fibrosis
Unilateral ureteral obstruction (UUO) was performed in
adult female mice, as previously described [7, 18, 19].
Briefly, mice were anesthetized with isofluorane (1 %,
inhaled). UUO was induced by left ureteral ligation using
a 4-0 silk tie suture at two points. Sham operated mice
underwent the same procedure except that left ureter was
only exposed by flank incision, served as controls (n = 6).
Kidneys were harvested on d3 (n = 6), d7 (n = 17), and d14
(n = 6).
Assessment of kidney fibrosis
Histological analysis of fibrosis was performed on fixed
renal tissue, embedded in paraffin, and sectioned at a
thickness of 4 μm. Connective tissue deposition was
examined with Picrosirius Red Stain Kit (Polysciences, Inc,
Warrington, PA, USA) and collagen I (1:100, Millipore,
Billerica, MA, USA), staining, as we have previously
described [20–22]. Additionally, co-staining of CoRL and a
myofibroblast marker alpha smooth muscle actin (αSMA,
1:10.000; Sigma, Saint Louis, MI, USA) were performed to
determine whether CoRL become myofibroblasts in kidney
fibrosis.
Detection of tdTomato reporter
In order to visualize tdTomato reporter labeling used to
label CoRL in RenCreER mice, kidneys were fixed in
10 % buffered formalin, embedded in paraffin, and
sectioned at a thickness of 4 μm. Kidney sections under-
went deparaffinization, heat-mediated antigen retrieval in
citrate buffer pH 6.0, and blocking unspecific background
(Accurate, San Jose, CA, USA). Immunofluorescent stain-
ing for the tdTomato reporter was performed with Dye-
Light 594-conjugated RFP (Red Fluorescent Protein) rabbit
antibody (1:100, Rockland Immunochemicals for Research,
Gilbertsville, PA, USA) at room temperature for 1.5 h.
tdTomato fluorescent signal is discernable in non-paraffin-
embedded tissue only.
Identification of cell proliferation
BrdU (5-Bromo-2-deoxyridine) incorporation assay was
used to quantitate cell cycle entry and proliferation. 10 μl
of BrdU (Amersham Cell Proliferation Labeling Reagent,
GE Healthcare Life Sciences, Little Chalfont, UK) per gram
body weight was administered via IP on alternate days fol-
lowing UUO. Double immunostaining was performed for
BrdU and tdTomato. Antibody paraffin embedded tissue
was prepared and blocked as described above. Avidin/bio-
tin blocking (Vector Laboratories, Burlingame, CA, USA)
was performed to block endogenous biotin and prevent
unspecific staining while using biotin-streptavidin labeling
system. Tissue was incubated overnight at 4 °C with a
primary mouse anti-BrdU (1:200, Amersham, GE Life
Sciences, Buckinghamshire, UK). This was followed with a
biotinylated goat anti-mouse antibody (1:500, Jackson
Immunoresearch Laboratories, Inc, West Grove, PA,
USA) incubated at room temperature for 1 h. The
signal was amplified by incubation with streptavidin-
conjugated with Alexa Fluor 488 (1:100; Invitrogen,
Grand Island, NY, USA) for 45 min. Negative control
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staining was performed by omitting primary antibody
staining.
Assessment of vascular changes
Endothelial marker staining CD31 (PECAM-1) was
performed to examine changes in microvascular dens-
ity, and to demonstrate any perivascular location of
CoRL and pericytes. Rat anti-mouse CD31 (1:100;
Dianova, Hamburg, Germany) was incubated over-
night at 4 °C following incubation with secondary
anti-rat antibody conjugated with Alexa Fluor 647
(1:100 Invitrogen).
Pericytes were identified by the expression of NG2 and
PDGFRß. To identify pericytes derived from CoRL, triple
imunostaining was performed on frozen tissue sections as
follows. Rabbit anti-NG2 antibody (1:100; Millipore,
Billerica, MA, USA) was incubated overnight at 4 °C,
followed by biotinylated anti-rabbit antibody (1:500; Vec-
tor) incubation at room temperature for 1 h, and strepta-
vidin conjugated with Alexa Fluor 647 (1:100; Invitrogen,
Grand Island, NY, USA) for 45 min. To prevent non-
specific staining for the primary antibodies from the same
species pre-incubation with anti-rabbit IgG Fab (1:25;
Jackson ImmunoResearch Laboratories, West Grove, PA,
USA) was followed by rabbit IgG Fab incubation (1:25;
Jackson ImmunoResearch Laboratories). Rabbit anti-
PDGFRß antibody (1:100; Abcam, Cambridge, MA, USA)
was incubated with tissue sections overnight at 4 °C.
Secondary donkey anti-rabbit antibody conjugated with
Alexa Fluor 488 (1:100, Invitrogen) was incubated for 1 h
at room temperature. Finally, anti-tdTomato antibody was
applied.
To examine hypoxia-activated locations in UUO, HIF-
2α (hypoxia inducible factor-2 α) staining was performed
together with tdTomato reporter staining on frozen tis-
sue sections. Rabbit anti-HIF-2α antibody (1:200; Novus
Biological, Littleton, CO, USA) was incubated overnight
at 4 °C, followed by biotinylated anti-rabbit antibody
(1:500; Vector) incubation at room temperature for 1 h,
and streptavidin conjugated with Alexa Fluor 647 (1:100;
Invitrogen) for 45 min. Positive staining was assessed
based on nuclear HIF-2α localization confirmed by
DAPI staining.
Image analysis and statistical analysis
Reporter positive-, BrdU- stainings were quantified on
20 images of kidney cortex/medulla using 200x total
magnification. Fluorescent imaging was performed using
EVOS®FL Cell Imaging System (Life Technologies). One-
way ANOVA with Bonferroni post hoc test was used to
compare groups with P ≤ 0.05 as a criterion for statistical
significance. Data were presented as means ± SEM. All
data were analyzed in GraphPad Prism 5.0 (GraphPad
Software, La Jolla, CA, USA).
Results
UUO results in microvascular rarefaction and increased
collagen staining
Additional file 1: Figure S1A shows the expected classical
hydronephrosis in the obstructed kidney as reported by
others [1, 4], with compensatory growth in the non-
obstructed kidney. Prolonged ureteral obstruction leads to
renal parenchymal damage and as a consequence loss of
kidney mass. Following UUO, there was a decrease of the
ligated/non-ligated kidney weight ratio d7 (1.00 ± 0.04 vs.
0.79 ± 0.3, p < 0.01 vs. sham kidney) and d14 (1.00 ± 0.04
vs. 0.64 ± 0.07, p < 0.001 vs. sham kidney) (Additional file 1:
Figure S1B).
Loss of microvessels affects oxygen supply and toxin
removal [23]. In chronic kidney disease, microvascular
rarefaction contributes to tubulo-interstitial scarring and
is a potential therapeutic target [19, 24]. Following UUO,
there was a progressive decline in endothelial CD31
staining in the cortex and medulla on d7 and d14 com-
pared to the sham kidney (Additional file 1: Figure S1C).
Picrosirius Red staining labels collagen I and III fibers. As
expected, interstitial collagen levels were very low in sham
kidneys (Additional file 1: Figure S1D). Following obstruc-
tion, there was a progressive increase of picrosirius red
staining on days 3, 7, and 14 (Additional file 1: Figure
S1D). The percentage area of Picrosirius Red staining
increased from 3.05 ± 1.02 % in sham kidney to 5.61 ± 0.64
on day 3 (P > 0.05), through 9.86 ± 1.48 on day 7 and was
the highest on day 14 (14.03 ± 2.8, p < 0.01 vs. sham, and
p < 0.05 vs. day 3) (Additional file 1: Figure S1E). Taken
together in this mouse strain, the decrease in endothelial
cell staining and increase in fibrosis are consistent with
classic interstitial changes in UUO.
Interstitial CoRL number increases in UUO
Cortical changes
Double-staining was performed for RFP (to mark labeled
CoRL), and CD31 (endothelial cell marker). Similar to
what we have previously reported [16], when CoRL re-
porter mice are given tamoxifen to induce permanent
CoRL reporting, and then undergo a sham procedure as
control, labeled CoRL (RFP positive, red color) in the
cortex are typically localized and restricted to juxtaglo-
merular (JG) compartment (Fig. 2a, arrowheads) and
along afferent arterioles (Fig. 1a, arrow). Following
UUO, CoRL were also detected within the capillary
loops of an occasional glomerulus (Fig. 1b), and also in
peritubular locations (Fig. 1c).
In UUO there were no significant changes in the number
of total cortical CoRL (including JG, afferent arterioles,
peritubular and glomerular CoRL) (Fig. 1d). There was a
slight trend in the CoRL number increasing in the JG after
two weeks of kidney injury, however these changes were
not significant (Fig. 1e). Interestingly, at d3 post UUO,
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glomerular CoRL number increased compared to sham
kidney (0.02 ± 0.02 vs. 0.15 ± 0.03, p < 0.01 vs. d3), and d14
(0.04 ± 0.02 vs. d3, p < 0.05) (Fig. 1f). In contrast, peritubu-
lar CoRL number increased significantly at d7 (0.23 ± 0.05
vs. 0.04 ± 0.02, p < 0.05 vs. sham), (Fig. 1g). On d3 (0.13 ±
0.05, p > 0.05) and d14 (0.19 ± 0.07, p > 0.05) following
UUO, there were trends towards an increase in peritubular
CoRL number (Fig. 1g).
Medullary changes
In the medulla of sham kidneys, labeled CoRL were
detected in vasa recta (Fig. 1i). At d7, increased RFP la-
beled CoRL were typically adherent to underlying vessels
(Fig. 1j). Noteworthy was that at d14, the majority of
labeled CoRL were no longer adherent to underlying ves-
sels, but rather were detected outside the vascular bed
(Fig. 1k). Following UUO, there was a trend to an increase
in the number of medullary CoRL at d3 (1.03 ± 0.19 vs.
0.81 ± 0.17, p > 0.05 vs. sham). However, there was a
significant increase in medullary CoRL on d7 (1.62 ± 0.13,
p < 0.01 vs. sham). The number of labeled CoRL was lower
at d14 post UUO (0.92 ± 0.21, p < 0.05 vs. d7), and was no
different from sham kidneys (P > 0.05) (Fig. 1h).
These results show that the number of labeled CoRL in-
creases in peritubular locations in both cortex and medulla
on d7. By d14, the majority of labeled (almost 100 %) CoRL
had detached from their vasculature, raising the possibility
of an ultimate myofibroblast fate.
Fig. 1 The number of cells of renin lineage (CoRL) increases beyond the JG location following UUO. CoRL were identified by RFP reporter staining (red),
endothelial cells were labeled with CD31 staining (green). Nuclei are labeled with DAPI (blue). (a–g) CoRL in Cortex. (a) Representative images show that in
sham-operated mice, labeled CoRL (arrowheads) are predominantly localized to the juxta-glomerulus, with fewer detected along afferent arterioles (arrow).
(b) At d7 post UUO, occasional labeled CoRL were detected in glomerular capillary loops. (c) Labeled CoRL were rarely detected in peritubular locations at
day 14. Quantification: (d) Total cortical CoRL number was not statistically significant following UUO, (e) the same was found when CoRL were quantified
exclusively in JG compartment. However, (f) there was a significant increase of intraglomerular CoRL at d3, and (g) peritubular CoRL at d7 and
d14. (h–k) CoRL in Medulla. (h) Quantification - total CoRL number in the medulla was significantly increased on day 7 following UUO. (i) In the medulla
of the sham kidney, CoRL were restricted to vasa recta. (j) Following UUO there was an increase of CoRL in vasa recta on day 7 (arrowheads).
(k) 14 days after UUO, a subset of CoRL localized away from any vessels, being present in the interstitium
Stefanska et al. BMC Nephrology  (2016) 17:5 Page 4 of 11
CoRL proliferate and migrate following UUO
Having observed increased CoRL number in the medulla
following UUO, we next asked whether this was due to cell
proliferation by administering repeated BrdU pulses. As ex-
pected, there was an increase of tubular cell BrdU staining
following UUO, used as an internal positive control (Fig. 2b,
c, open arrowheads). In the medulla, CoRL BrdU staining
was only detected on UUO day 7 (Fig. 2b). Of the total
medullary CoRL number, 3.78 ± 5.28 % stained for BrdU.
Several proliferating medullary CoRL exhibited a marked
shape change that gave the appearance of a migratory
phenotype (Fig. 2c, arrowhead). Moreover, using CD31
staining to highlight endothelial cells, occasional labeled
cells were detected within the lumen of medullary vessels
(Figs. 2d, d’). These data show that CoRL proliferation was
not detected in the cortex, including their original location
in the juxta-glomerulus. However, a subset of CoRL that
had migrated did proliferate when in the medulla.
Renin is not expressed in interstitial CoRL
At 70 days postnatal in a mouse, renin expression is
restricted to the JG [25]. Because our data showed an
increase of interstitial CoRL (i.e. beyond the JG compart-
ment) we next determined if these cells retained renin
protein. Double staining for renin and the RFP reporter
shows that in both sham (not shown) and obstructed
kidneys, renin staining was restricted to cells in the JG
only (Additional file 2: Figure S2A and B). These results
support the concept that renin lineage cells, when chal-
lenged, can take on different cell phenotype and in doing
so, no longer express renin [15, 26].
CoRL co-express pericyte markers following UUO
Both CoRL and pericytes derive from Foxd1 lineage cells
[10]. CoRL are primarily located in the JG compartment
and afferent arterioles, whereas renal pericytes are typic-
ally located around peritubular capillaries and vasa recta
[27, 28]. Foxd1 lineage tracking demonstrated that peri-
cytes and perivascular fibroblasts are major cellular con-
tributors to kidney fibrosis [7, 8]. To determine if CoRL
contribute to pericyte recruitment following a compro-
mised microvasculature post UUO, triple staining was
performed for the reporter (RFP), pericyte markers
(PDGFßR, NG2).
Staining for endogenous pericyte markers was overall in-
creased in UUO, similar to published data regarding peri-
cytes accumulation in fibrosis [7, 8, 29]. In the sham
kidney, NG2+/PDGFRß+ staining was detected in mesangial
cells, afferent arterioles, peritubular capillaries, and vasa
recta (Fig. 3a, d). At d3 post UUO there was an increase of
interstitial PDGFRß expression, whereas NG2 staining was
fainter in both cortex and medulla (not shown). However,
at d7 post UUO, there was an increase of staining for both
PDGFßR and NG2 (Fig. 3b, e), which persisted at d14
Fig. 2 Proliferative and migratory phenotype of CoRL in UUO. (a–c) To detect proliferation in CoRL, double-staining was performed for Red fluorescent
protein (red) to identify CoRL, and BrdU (green) to examine cell proliferation. Nuclei are labeled with DAPI (blue). Medulla: (a) CoRL did not co-express
BrdU in sham kidneys. ( b) At day 7 post UUO, a subset of CoRL co-expressed BrdU (yellow color; arrow shows example). The inset demonstrates this at
higher magnification. As expected, other peritubular cells stained for BrdU (open arrowheads). (c) Some dual CoRL+/BrdU+ cells displayed elongated
shape with long cellular processes suggesting cell motility when viewed at high power (inset). (d) To better define the subset of labeled
CoRL that appeared to be migrating based on their shape (identified by RFP staining, arrowheads), double staining was performed for
the endothelial cell marker CD31 (green, arrows). (d’) On occasion, CoRL were detected within vessels in the medulla
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(Fig. 3c, f). Triple staining revealed that labeled CoRL
(identified by RFP staining) in the interstitium co-expressed
both PDGFßR and NG2 at days 3, 7 and 14 post UUO.
The aforementioned results show that labeled CoRL always
co-express pericyte markers and this is consistent with
them likely being truly pericytes. In such a capacity, CoRL
may indeed participate in vessel remodeling in UUO.
A subset of pericytes that have detached from vessels
express increased αSMA
To determine if CoRL become myofibroblasts and
localize to scarred areas, triple staining was performed
for RFP (CoRL reporter), αSMA (a marker of VSMC
which appears de novo in myofibroblasts), and CD31
(endothelial marker).
Cortical changes
In the sham kidney cortex staining for αSMA and CoRL is
present in afferent arterioles (Fig. 4a, insets, arrowhead).
Post UUO, all interstitial CoRL in the cortex co-expressed
αSMA at days 3, 7, 14. At d3, CoRL displayed perivascular
location (not shown). In addition to peri-endothelial loca-
tion (Fig. 4b, insets, arrowhead), CoRL were also found
outside capillary bed at d7 post UUO (Fig. 4b, arrow). 2w
post UUO when CoRL had migrated away from the ves-
sels, they continued to express αSMA, suggesting a myofi-
broblast nature (Fig. 4c, insets, arrowhead).
Medullary changes
In the sham kidney medulla, CoRL are present in vasa recta
only, and these cells co-express αSMA (Fig. 4d, insets,
arrowhead). Following UUO, interstitial CoRL co-express
αSMA on days 3, 7 and 14. At d7 CoRL were detected
occasionally in extravascular locations (not shown), while
also being peri-vascular (Fig. 4e, insets, arrowheads). By co-
staining with CD31 we confirmed that the majority of
CoRL (almost 100 %) that had detached from the under-
lying vessels on d14 are αSMA-expressing myofibroblasts
(Fig. 4f, insets, arrowheads).
HIF-2α is activated in CoRL in the JG compartment and in
afferent arterioles in UUO
Hypoxia secondary to vasoconstriction and microvascular
rarefaction is an important mechanism mediating tubu-
lointerstitial injury [30]. In the kidney, HIF-2α is activated
by hypoxia in interstitial fibroblasts-producing erythropoi-
etin [31] and in endothelial cells [32, 33]. HIF stabilization
and permanent hypoxic state can be achieved in a mouse
Fig. 3 Interstitial CoRL co-express pericytes markers. To label pericytes, antibody staining against PDGFRß (green) and NG2 (red) was performed,
CoRL were identified by RFP staining, nuclei are labeled with DAPI. (a–c) Cortex: (a) Representative images show that in sham-operated mice,
CoRL co-express pericyte markers in JG (arrowhead). Insets show high power images of juxtaglomerular CoRL. In UUO, there was an accumulation
of interstitial pericytes (orange color). Interstitial CoRL were found in peritubular areas co-expressing pericyte markers at (b) 7 day post UUO,
and (c) 14 days post UUO. Insets show high power images of CoRL. (d–f) Medulla: (d) Sham medulla shows CoRL co-expressing pericyte
markers in vasa recta (arrowheads). Insets show high power images. Pericyte marker staining increases in UUO (orange color). Interstitial CoRL were co-
labeled with pericyte markers at (e) day 7 post UUO, (f) day 14 post UUO. Insets show high power images of interstitial CoRL
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model by Vhl deletion. Targeted deletion of Vhl in the cells
of renin lineage demonstrates HIF-2α expression along the
afferent arterioles, glomerular vascular poles, and intraglo-
merular cells [15]. Therefore, cells in the juxta-glomerulus
and afferent arterioles respond to hypoxia by activating
HIF-2α. To examine changes in HIF-2α might in CoRLs
following UUO, co-staining was performed for RFP (CoRL
label) and HIF-2α.
Cortical changes
In sham-operated kidneys, HIF-2α staining was detected
in the cytoplasm of a subset of labeled CoRL in the JG
compartment (Fig. 5a, inset, arrowheads). HIF-2α staining
in the cytoplasm is considered the non-active form,
whereas when active, HIF-2α translocates to the nucleus
[34]. Following UUO on days 3, 7 and 14, HIF-2α staining
was detected in the nucleus (co-localized with DAPI) in
labeled CoRL in the JG compartment and afferent arteri-
oles (Fig. 5b–d, insets, arrowheads). These subcellular
changes in the location of HIF-2α staining were consistent
with the presence of the inactive form in sham kidneys,
but the active form in labeled CoRL post UUO in the JG
compartment.
Medullary changes
In the sham kidney medulla, HIF-2a was not detected in
labeled CoRL (Additional file 3: Figure S3A) In contrast
to the cortex, HIF-2α never localized to labeled CoRL in
the medulla post obstruction. Thus was not a false
negative result because following UUO there was a
Fig. 4 αSMA is expressed by interstitial CoRL in fibrosis. Red fluorescent protein (red) staining identified CoRL, αSMA (green) staining was used to mark
vascular smooth muscle cells and myofibroblasts, CD31 staining denotes endothelial cells (magenta). Nuclei are labeled with DAPI (blue). (a) In the sham
cortex, CoRL were found in JG compartment (arrowheads, insets). (b) At d7 post UUO, CoRL were localized to perivascular area (arrowhead, insets),
however, some CoRL were no longer supporting microvessels (arrow). (c) At 14 days post UUO, majority of CoRL (arrowhead) were found outside vascular
bed and expressing αSMA suggesting the myofibroblastic conversion. Insets show high power images of merged and single stained panels (d) In the
sham medulla, CoRL were found in vasa recta (arrowhead) and co-expressing αSMA. (e) 7 days following UUO, CoRL were still found surrounding
endothelial cells (arrowhead, insets). (f) 14 days post UUO, CoRL and localized to avascular areas and expressing αSMA (arrowhead). Insets show high
power images of merged and single stained panels
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progressive increase in HIF-2α staining of interstitial
cells of non-CoRL type (Additional file 3: Figure S3B, C,
and D, arrowheads).
Discussion
UUO is characterized by hypoxia, interstitial vascular loss
and progressive kidney fibrosis. The compensatory mech-
anisms that might attempt to counter these events are not
well understood. We demonstrated that following UUO,
the number of medullary cells of renin lineage (CoRL)
number increases due to cell proliferation and migration.
Although CoRL initially appear to be reparative of intersti-
tial microvessels following UUO by transdifferentiating in
to pericyte-like cells, they are likely ultimately injurious by
transdifferentiating into myofibroblast-like cells. These
changes are preceded by activation of HIF2a in CoRL in
the juxta-glomerular compartment following UUO.
The first major finding from these studies was that the
number of CoRL increases following UUO. We used indu-
cible Ren1cCreER xRs-tdTomato-R reporter mice to fate
map a subset of CoRL that were permanently labeled spe-
cifically during the period of tamoxifen induction. The dis-
tribution of cells-expressing renin is very different during
development compared to adults [9]. Therefore, labeling
mice at 7–8 weeks of age focuses on adult CoRL that
derive from the juxtaglomerular (JG) compartment.
We next asked how might CoRL number increase fol-
lowing UUO? A first consideration was migration, from
their original location in the JG to the medulla. Several
lines of evidence help support this. First, using an indu-
cible reporter system, labeled CoRL in the cortex were
restricted to the JG. Thus, the presence of labeled CoRL
in the intracapillary loops of some glomeruli, and in the
cortical interstitium is in keeping with them migrating.
Second, many CoRL in the cortex and medulla had an
elongated shape, reminiscent of a migrating cell. Third,
several interstitial vessels contained labeled CoRL within
their lumens. Proliferation is another mechanism that
might explain the twofold increase in medullary CoRL
post UUO. To this end, we frequently performed BrdU
pulse chases to maximally capture cell proliferation.
BrdU staining was detected in a subset of CoRL in the
cortex and medulla, but not in the JG. Moreover, several
of CoRL with elongated shapes stained for BrdU. These
data suggest that once CoRL had moved from the JG, a
subset proliferated. However, we cannot exclude the
possibility that native CoRL in the medulla did not
proliferate, not migrate. Taken together, the increase in
medullary CoRL post UUO is likely due to a combin-
ation of proliferation in CoRL that had migrated away
from the JG, migration of non-proliferating CoRL and
proliferation of pre-exisiting CoRLs in the medulla.
Fig. 5 Nuclear translocation of HIF-2α in JG and afferent arteriole in UUO. Red fluorescent protein (red) staining identified CoRL, HIF-2α (green)
staining was used to detect hypoxia-activated cells. Nuclei are labeled with DAPI (blue). In the sham kidney cortex, there was (a) a cytoplasmic
HIF-2α staining in JG cells (inset shows single panel colors, arrowheads indicates the same cell). In UUO kidney, there was an accumulation of
HIF-2α staining in the nuclei in afferent arterioles and JG (insets show single panel colors, arrowheads indicates the same cell) on (b) day 3, (c) day 7,
(d) day 14 following kidney injury
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The second major finding in these studies was the
transdifferentiation of medullary CoRL in to pericytes or
myofibroblasts. Several lines of evidence show that CoRL
have marked plasticity under certain conditions [13–16].
Accordingly, we next asked what, if any, cell type did
CoRL transdifferentiate into in the medulla following
UUO. The first clue that they likely were transdifferen-
tiating was the loss of their endocrine function by virtue
that they no longer expressed the renin protein. Second,
because at d7 labeled CoRL were largely confined to
surrounding interstitial vessels, we explored the possibil-
ity that a subset were transdifferentiating in to pericytes.
Indeed, non-renin expressing labeled CoRL co-expressed
the pericyte markers NG2 and PDGFRß. Indeed, CoRL
have been reported to transdifferentiate into pericytes
during development [9] and in glomerular disease [16].
We can only speculate that the transdifferentiation of a
subset of CoRL to pericytes early in disease is an attempt
to maintain or even replace native pericytes, and thus
the interstitial vasculature.
Detached pericytes can differentiate into collagen-
producing myofibroblasts [7, 19]. Here, we report that
a subset of CoRL later underwent further changes to
that more consistent with a myofibroblast. At day 14
post UUO, the majority of labeled interstitial CoRL
were away from any blood vessels. Because these
areas were typified by interstitial fibrosis, we asked if
CoRL were transdifferentiating into myofibroblasts.
Indeed, a subset of CoRL did begin to express aSMA,
suggesting that they acquired a pro-fibrotic pheno-
type. It is not clear which of the following scenarios
occurred first: a decrease in interstitial vessels (i.e. re-
duced CD31 staining) forced pericyte-like CoRL to
detach, and/or if the detachment of pericyte-like
CoRL lead to unhealthy underlying vessels, followed
by rarefaction. Regardless, it is likely that similar to
other native cells in the interstitium that acquire
myofibroblast-like features, the subset of CoRL doing
so also likely contribute to the increased fibrosis later
in UUO. Finally, our data are in agreement with the
current view that Foxd1 lineage cells contribute to fi-
brosis [35] especially that CoRL have been recently
shown to derive from Foxd1+ cells [10].
Hypoxia is a common pathway for chronic kidney dis-
ease, including UUO [36, 37]. During kidney obstruction,
renal blood flow is reduced as a consequence of pre-
glomerular vessel constriction that in turn impairs post-
glomerular/peritubular perfusion [38]. HIF-2α is activated
in interstitial and endothelial cells in hypoxia [32, 33].
Extracellular matrix deposition further propagates hypoxia
to the tubulointerstitium since it increases the distance be-
tween capillaries and tubules, decreasing oxygen diffusion
[39]. In general, HIF-1 and -2 are both activated in hyp-
oxia, but in a different manner: HIF-2 is activated in mild
hypoxia <5 % O2 for many hours (still upregulated after
72 h), whereas, HIF-1 is rapidly induced at 1 % O2 to medi-
ate acute responses, and declines to the low levels within
72 h [40]. This suggests that HIF-2α has a role in the adap-
tation to chronic hypoxia, where it is the main regulator of
erythropoietin production [41], vascular tumorigenesis
[42], cell proliferation [43], and vessel remodeling in dis-
ease [44, 45]. Hypoxia is also associated with stem cell
phenotype, pluripotent stem cell culture at hypoxic condi-
tions (5 % O2) stabilize HIF-2α, increase proliferation and
stem cell marker expression [46].
The third major finding was that HIF-2α, a hypoxia-
activated factor, is induced in CoRL in the JG and affer-
ent arterioles following UUO. The HIF-2α staining pat-
tern shifting from a cytoplasmic subcellular location
before UUO to a nuclear location HIF-2α on day 3 post
UUO is very suggestive of HIF-2α changing from its
inactive form to an active form. Although this
phenomenon preceded the increase in CoRL number in
the intersitium, activated HIF2a persisted in a subset of
CoRL at all time points studied. There is precedence for
HIF in CoRL. Kurtz et al. mimicked chronic hypoxia in
CoRL by the deletion of Hippel-Lindau protein, and
showed increased HIF-2α expression along the afferent
arterioles, glomerular vascular poles, and intraglomeru-
lar cells [15]. Also perhaps relevant to the current stud-
ies is that the chronic activation of HIF-2α transforms a
subset of cells in the JG compartment into fibroblasts-
like cells [47]. Taken together, we propose that a likely
mechanism that underlies the transdifferentiation of
CoRL in the JG following UUO is the activation of HIF-
2α. Further studies are needed to prove if HIF-2α favors
a pericyte-like and/or myofibroblast-like transdifferentia-
tion of CoRL in UUO.
This study has some limitations. First, the study is
largely descriptive as we focus on association between
HIF-2α and CoRL activation. However there is sufficient
literature to support our proposed claim that HIF-2α may
be a causative factor leading to CoRL migration and prolif-
eration. JG area has been shown to display marked plasti-
city in disease settings [13–16]. Also, developmental
studies demonstrate that arterioles are the source of peri-
cyte recruitment [48]. Second, UUO model does not
provide functional data [49, 50]. One may argue that
only a small number of CoRL is involved in vascular
remodelling in UUO, however in an inducible fate-
mapping approach only a fraction of cells is labelled (as
we observe glomeruli without labelled CoRL). Import-
antly, the strength of this approach is that it allows to
faithfully track the subpopulation of CoRL that were
permanently labeled during tamoxifen induction. Fi-
nally, it adds to the pool of known pro-fibrotic progeni-
tors arteriolar-derived myofibroblasts. Third limitation
of the study is a gender bias since we have only used
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female mice. Most of the studies use male mice and
rats and the pro-injury effect of androgens in renal in-
jury in males is well documented [51, 52]. Nevertheless,
in our UUO model females demonstrated the classical
features of renal injury.
Conclusions
In summary, this study demonstrated that CoRL are
resident kidney progenitors that can respond to vascular
injury by proliferation and migration to possibly partici-
pate in vessel remodeling. However, with time, CoRL
ultimately undergo transition into myofibroblast-like
cells, which might favor fibrosis rather than repair. The
role of HIF-2a in CoRL needs further exploration.
Additional files
Additional file 1: Figure S1. UUO induces kidney fibrosis and reduces
vascular density in Ren1cCre mice. (A) Following ureteral obstruction of
the right kidney, the ureter is filled with urine. Non-obstructed kidney
(contralateral) undergoes hypertrophy. (B) Reduced weight ratio of
obstructed/non-obstructed kidney on day 7 and 14 after UUO. (C) Endothelial
cells, identified by CD31 staining (green), decrease in the cortex and medulla
following UUO on day 7 and 14 compared to sham kidneys. Examples
of capillary rarefaction are marked with an asterisk (*). (D) Picrosirius
Red staining was examined by polarized light microscopy. Collagen
fibers were barely detectable in sham kidneys. Interstitial Picrosirius
Red staining was increased on days 3, 7 and 14 following UUO. (E) Fibrosis
quantification based on Picrosirius Red staining score shows a gradual increase
of fibrosis in UUO. Data are represented as mean ± SEM. (PNG 652 kb)
Additional file 2: Figure S2. Renin staining is limited to labeled CoRL
in JG and afferent arterioles. Red fluorescent protein staining identified
CoRL (red), renin staining indicates renin-producing cells (green). DAPI
(blue) staining labels nuclei. At 7 days post UUO, (A) in the cortex, renin
staining was detected in classical JG location (arrow) (B) in the medulla
there was no renin staining found, interstitial CoRL were negative for
renin. (PNG 431 kb)
Additional file 3: Figure S3. HIF-2α is not activated in interstitial CoRL.
Red fluorescent protein (red) staining identified CoRL, HIF-2α (green) staining
was used to detect hypoxia-activated cells. Nuclei are labeled with DAPI (blue).
(A) Sporadic HIF-2α-expressing cells were found in sham kidney. Following
UUO, there was an increase of HIF-2α-activated cells (arrowheads) at (B) d3,
(C) d7, (D) and d14. However, none of interstitial CoRL expressed HIF-2α
(arrows). (PNG 1063 kb)
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